Cipla Ltd. — Capital/Financing Update 2025

May 29, 2025

==> picture [84 x 30] intentionally omitted <==

29[th] May 2025

(1) BSE Limited (2) National Stock Exchange of India Limited Listing Department, Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 Scrip Code: 500087 Scrip Code: CIPLA EQ

• (3) SOCIETE DE LA BOURSE DE LUXEMBOURG

Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Update on acquisition of shares in AMPIN Energy C&I Eighteen Private Limited

Dear Sir/Madam,

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and further to our intimation dated 19[th] May 2025, we hereby notify that the Jay Precision Pharmaceuticals Private Limited, subsidiary of the Company has completed acquisition of 26% stake in AMPIN Energy C&I Eighteen Private Limited on 28[th] May 2025.

Please take the above information on record.

Yours faithfully,

For Cipla Limited

RAJENDR Digitally signed by RAJENDRA A KUMAR KUMAR CHOPRA Date: 2025.05.29 CHOPRA 18:16:36 +05'30' Rajendra Chopra Company Secretary

Prepared by: Mandar Kurghode

Cipla Ltd.

Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India

P +91 22 41916000 F +91 22 41916120 W www.cipla.com E-mail contactus@cipla.com Corporate Identity Numbe r L24239MH1935PLC002380